@inproceedings{inproceedings, title  = {{Adjusting for treatment crossover in the BREAK-3 metastatic melanoma trial for dabrafenib: Preliminary analysis}},

 url = {{}},

 year = {{2013}},

 month = {{5}},

 author = {{Latimer N and Abrams KR and Amonkar M and Stapelkamp C and Swann RS}},

 volume = {{31}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2024/12/22}}}